Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Neutrophilic eccrine hidradenitis.

B Vion¹, H Alvero

¹Department of Dermatology, University Hospital, Lausanne, Switzerland.

Dermatologica

|January 1, 1991

Summary

Neutrophilic eccrine hidradenitis, a skin reaction, can occur after chemotherapy for acute myelogenous leukemia. This case highlights the importance of recognizing this adverse drug reaction during cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Private practice of internal medicine. Is it possible out of academic hospitals?].

La Revue de medecine interne·2012

Same author

Cutaneous plasmacytosis: an unusual presentation sharing features with POEMS syndrome?

Dermatology (Basel, Switzerland)·2001

Same author

Necrobiosis lipoidica and silicotic granulomas on Muller's phlebectomy scars.

Dermatology (Basel, Switzerland)·1997

Same author

Angiosarcoma of the scalp. A case with a particularly aggressive evolution.

Dermatology (Basel, Switzerland)·1995

Same author

Targetoid hemosiderotic hemangioma.

Dermatology (Basel, Switzerland)·1992

Same author

Mycetoma of the foot due to Fusarium sp. treated with oral ketoconazole.

Dermatology (Basel, Switzerland)·1992

Area of Science:

Dermatology
Oncology
Pharmacology

Background:

Neutrophilic eccrine hidradenitis (NEH) is an uncommon adverse reaction to certain medications.
Acute myelogenous leukemia (AML) treatment often involves chemotherapy agents known to induce skin toxicities.

Observation:

A 57-year-old male patient with AML developed a characteristic neutrophilic eccrine hidradenitis eruption.
The eruption appeared following treatment with cytarabine and mitoxantrone chemotherapy.

Findings:

The case presented is typical of neutrophilic eccrine hidradenitis.
Chemotherapy-induced neutrophilic eccrine hidradenitis is a recognized, albeit infrequent, complication.

Implications:

Early recognition and management of this condition are crucial for patient comfort and treatment adherence.
This case contributes to the literature on chemotherapy-related dermatologic adverse events in AML patients.

Related Experiment Videos